Agilent Technologies, Inc. (NYSE:A) SVP Jacob Thaysen sold 22,583 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $70.41, for a total value of $1,590,069.03. Following the completion of the sale, the senior vice president now owns 63,042 shares of the company’s stock, valued at approximately $4,438,787.22. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Agilent Technologies, Inc. (A) opened at $68.69 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies, Inc. has a 12 month low of $43.27 and a 12 month high of $70.93. The stock has a market capitalization of $22,283.37, a P/E ratio of 29.22, a PEG ratio of 2.09 and a beta of 1.27.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The firm had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the firm earned $0.59 earnings per share. The business’s revenue was up 7.0% compared to the same quarter last year. sell-side analysts anticipate that Agilent Technologies, Inc. will post 2.58 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a dividend of $0.149 per share. The ex-dividend date is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.87%. Agilent Technologies’s payout ratio is 25.24%.

A number of equities analysts have commented on A shares. BidaskClub raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Sunday, August 6th. Jefferies Group reaffirmed a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 9th. J P Morgan Chase & Co reaffirmed an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 16th. Bank of America reaffirmed an “equal weight” rating on shares of Agilent Technologies in a research note on Tuesday, August 15th. Finally, Janney Montgomery Scott lifted their price target on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $68.34.

A number of hedge funds have recently modified their holdings of the stock. Steward Partners Investment Advisory LLC purchased a new stake in Agilent Technologies in the third quarter worth $213,000. Public Employees Retirement System of Ohio grew its stake in Agilent Technologies by 0.9% in the third quarter. Public Employees Retirement System of Ohio now owns 394,744 shares of the medical research company’s stock worth $25,343,000 after purchasing an additional 3,452 shares during the period. Coastline Trust Co grew its stake in Agilent Technologies by 20.1% in the third quarter. Coastline Trust Co now owns 10,280 shares of the medical research company’s stock worth $660,000 after purchasing an additional 1,720 shares during the period. Hahn Capital Management LLC grew its stake in Agilent Technologies by 1.0% in the third quarter. Hahn Capital Management LLC now owns 598,781 shares of the medical research company’s stock worth $38,442,000 after purchasing an additional 5,648 shares during the period. Finally, Americafirst Capital Management LLC purchased a new stake in Agilent Technologies in the third quarter worth $743,000.

TRADEMARK VIOLATION NOTICE: “Agilent Technologies, Inc. (A) SVP Sells $1,590,069.03 in Stock” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/12/02/agilent-technologies-inc-a-svp-sells-1590069-03-in-stock.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.